Balaxi Pharmaceuticals Limited

NSEI:BALAXI 株式レポート

時価総額:₹4.5b

Balaxi Pharmaceuticals 過去の業績

過去 基準チェック /36

Balaxi Pharmaceuticalsは、平均年間5.6%の収益成長を遂げていますが、 Healthcare業界の収益は、年間 成長しています。収益は、平均年間29.2% 26.6%収益成長率で 成長しています。 Balaxi Pharmaceuticalsの自己資本利益率は22.6%であり、純利益率は18.9%です。

主要情報

5.6%

収益成長率

1.4%

EPS成長率

Healthcare 業界の成長29.4%
収益成長率26.6%
株主資本利益率22.6%
ネット・マージン18.9%
前回の決算情報30 Jun 2024

最近の業績更新

Recent updates

These 4 Measures Indicate That Balaxi Pharmaceuticals (NSE:BALAXI) Is Using Debt Reasonably Well

Jul 30
These 4 Measures Indicate That Balaxi Pharmaceuticals (NSE:BALAXI) Is Using Debt Reasonably Well

Balaxi Pharmaceuticals Limited's (NSE:BALAXI) Share Price Could Signal Some Risk

May 29
Balaxi Pharmaceuticals Limited's (NSE:BALAXI) Share Price Could Signal Some Risk

Market Might Still Lack Some Conviction On Balaxi Pharmaceuticals Limited (NSE:BALAXI) Even After 38% Share Price Boost

Feb 10
Market Might Still Lack Some Conviction On Balaxi Pharmaceuticals Limited (NSE:BALAXI) Even After 38% Share Price Boost

Balaxi Pharmaceuticals (NSE:BALAXI) Has A Pretty Healthy Balance Sheet

Feb 09
Balaxi Pharmaceuticals (NSE:BALAXI) Has A Pretty Healthy Balance Sheet

Is Balaxi Pharmaceuticals (NSE:BALAXI) A Risky Investment?

Aug 08
Is Balaxi Pharmaceuticals (NSE:BALAXI) A Risky Investment?

The Trend Of High Returns At Balaxi Pharmaceuticals (NSE:BALAXI) Has Us Very Interested

May 20
The Trend Of High Returns At Balaxi Pharmaceuticals (NSE:BALAXI) Has Us Very Interested

A Look At The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Feb 03
A Look At The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Calculating The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Sep 06
Calculating The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Balaxi Pharmaceuticals (NSE:BALAXI) Knows How To Allocate Capital Effectively

Jun 03
Balaxi Pharmaceuticals (NSE:BALAXI) Knows How To Allocate Capital Effectively

Is Weakness In Balaxi Pharmaceuticals Limited (NSE:BALAXI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Mar 12
Is Weakness In Balaxi Pharmaceuticals Limited (NSE:BALAXI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Is Balaxi Pharmaceuticals Limited's(NSE:BALAXI) Recent Stock Performance Tethered To Its Strong Fundamentals?

Nov 27
Is Balaxi Pharmaceuticals Limited's(NSE:BALAXI) Recent Stock Performance Tethered To Its Strong Fundamentals?

収支内訳

Balaxi Pharmaceuticals の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NSEI:BALAXI 収益、費用、利益 ( )INR Millions
日付収益収益G+A経費研究開発費
30 Jun 242,4104546630
31 Mar 242,413-246570
31 Dec 232,621-526050
30 Sep 232,879-1066230
30 Jun 233,196-956880
31 Mar 233,3644607270
31 Dec 223,4495067510
30 Sep 223,2005456270
30 Jun 223,0385114660
31 Mar 222,7944773120
31 Dec 212,4164332090
30 Sep 212,4574211840
30 Jun 212,3734011770
31 Mar 212,3133811610
31 Dec 201,939312730
30 Sep 201,411228560
30 Jun 20938138360
31 Mar 2045661460
31 Dec 1941653180
30 Sep 1934240170
30 Jun 1923031130
31 Mar 1914020100
31 Dec 18791160
30 Sep 1815-330
30 Jun 180-820
31 Mar 180-820
31 Dec 17-6-1210
30 Sep 17-6-1110
30 Jun 17-6-810
31 Mar 170-210
31 Dec 160-110
30 Sep 160-110
30 Jun 160-110
31 Mar 160-110
31 Dec 152-110
31 Mar 152100
31 Mar 142100

質の高い収益: BALAXIには₹83.8M } という大きな 一回限りの 利益があり、過去 12 か月の財務実績が30th June, 2024に影響を及ぼしています。

利益率の向上: BALAXI過去に利益を上げました。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: BALAXIの収益は過去 5 年間で年間5.6%増加しました。

成長の加速: BALAXIは昨年収益を上げたため、収益成長率を 5 年間の平均と比較することは困難です。

収益対業界: BALAXI昨年収益を上げたため、昨年の収益成長をHealthcare業界 ( 30.6% ) と比較することは困難です。


株主資本利益率

高いROE: BALAXIの 自己資本利益率 ( 22.6% ) は 高い とみなされます。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘